Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression

Objectives. Features of deregulated Notch 1 signaling and NF-kappa B activation have independently been reported in cervical cancers. Here, we have extended these observations and examined both these pathways simultaneously in human cervical cancer tissue. Further, we have investigated the potential cross-talk between these pathways in a human cervical cancer derived cell line CaSki, which mirrors features of Notch activation as in the majority of human cervical cancers. Methods. Cervical tissue samples were analyzed for the expression of Notch 1, Jagged 1, Hes1, pAKT, NF-kappa B p50, NF-kappa B p65, I kappa B-alpha, Bcl-2, CyclinD1, Cdk9, c-Fos, and p53 by immunohistochemistry. A total of 352 samples were analyzed which included 69 normal cervical tissue, 132 preinvasive lesions and 151 squamous cell carcinomas of the uterine cervix. Dual immunofluorescent analysis was performed to evaluate the coexpression of Notch1 and NF-kappa B. Transcriptional reporter assays and xenografts were undertaken with CaSki cells. Results. Features of Notch1 activation as measured by intracellular Notch1, high levels of Jagged1, Hes1 and Cdk9 were paralleled by nuclear translocation of both NF-kappa B p50 and p65 with target gene expression (I kappa B-alpha, Bcl-2, and CyclinD1) in human cervical cancer sections. Reporter assays in CaSki cells are consistent with Notch being an upstream regulator of NF-kappa B. Further, the xenografts recreate key aspects of human cancer tissue. Conclusions. Results from this study suggest that there is a co-activation of Notch1 and NF-kappa B signaling pathways at the cellular level in the majority of human cervical cancers, with Notch as an upstream regulator. (c) 2006 Elsevier Inc. All rights reserved.